Quickly
Socially
Trending
Crypto
CIPLA
Medicine Manufactured by Same Company Being Sold at 2 Different Prices by Cipla and Torrent, Claims Doctor in LinkedIn Post; Raises Question on Price Disparity
Cipla Share Price Today, March 19: Cipla Stock Opens Higher but Slips 0.15% in Early Trade; Check Latest Price on NSE
Cipla Receives Final Approval From USFDA for Lanreotide Injection To Treat Tumours
Molnupiravir for COVID-19 Treatment: Domestic Pharma Majors Join Hands for Clinical Trial of the Oral Antiviral Drug to Treat Mild Infection
Moderna COVID-19 Vaccine in India Soon as Cipla Gets DCGI Nod to Import Vaccine for Restricted Emergency Use: Sources
Cipla Gets DCGI Nod to Import Moderna's COVID-19 Vaccine for Restricted Emergency Use in India, Say Sources
Close to Commit Over $1-BIllion to Moderna for COVID-19 Booster Vaccine; Provide Price Capping Waiver, Indemnity: Cipla to Govt
ViraGen: Cipla Launches Real-Time COVID-19 RT-PCR Testing Kit; Here's All About The Testing Kit
COVID-19 Antibody Cocktail Drug Casirivimab and Imdevimab Used to Treat Donald Trump Now Launched in India at Rs 59,750 Per Dose
Remdesivir Marketing Companies to Supply 53 Lakh Vials of Antiviral Drug for April 21 and May 16 Period to States/UTs: Govt
Cipla Gets DCGI Nod to Sell Favipiravir Under Brand 'Ciplenza' to Treat Mild And Moderate COVID-19 Patients
Cipla Gets Regulatory Nod from DCGI for Launch of Ciplenza to Treat Mild to Moderate COVID-19
Google Trends
